CoChat

Advanced lipoprotein testing for cardiovascular diseases risk assessment: a review of the novel approaches in lipoprotein profiling

Clouet-Foraison, Noémie, Gaie-Levrel, Francois, Gillery, Philippe, Delatour, Vincent · 2017 · Clinical Chemistry and Laboratory Medicine (CCLM)

The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.

Abstract

With the increasing prevalence of cardiovascular diseases (CVD) worldwide, finding reliable and clinically relevant biomarkers to predict acute cardiovascular events has been a major aim of the scientific and medical community. Improvements of the understanding of the pathophysiological pathways of the disease highlighted the major role of lipoprotein particles, and these past decades have seen the emergence of a number of new methodologies to separate, measure and quantitate lipoproteins. Those methods, also known as advanced lipoprotein testing methods (ALT), have gained acceptance in the field of CVD risk assessment and have proven their clinical relevance. In the context of worldwide standardization and harmonization of biological assays, efforts have been initiated toward standardization of ALT methods. However, the complexity of lipoprotein particles and the multiple approaches and methodologies reported to quantify them have rendered these initiatives a critical issue. In this context and to better understand these challenges, this review presents a summary of the major methods available for ALT with the aim to point out the major differences in terms of procedures and quantities actually measured and to discuss the resulting comparability issues.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1515/cclm-2017-0091

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 101

  1. 2010, Ion mobility analysis of lipoproteins
  2. 35. Robinson JG. What is the role of advanced lipoprotein analysis in practice? J Am Coll Cardiol 2012;60:2607–15.10.1016/j.jacc.2012.04.067Search in Google Scholar · doi:10.1016/j.jacc.2012.04.067search
  3. 18. Hirayama S, Miida T. Small dense LDL: an emerging risk factor for cardiovascular disease. Clin Chim Acta 2012;414:215–24.10.1016/j.cca.2012.09.010Search in Google Scholar PubMed · doi:10.1016/j.cca.2012.09.010search
  4. 25. Dominiczak MH. Apolipoproteins and lipoproteins in human plasma. In: Rifai N, Warnick GR, Dominiczak MH, editors. Handbook of lipoprotein testing, 2nd ed. Washington, DC: AACC Press, 2000:1–29.Search in Google Scholar
  5. 2014, Development and evaluation of a novel advanced lipoprotein test based on 2D diffusion ordered 1H-NMR spectroscopy [thesis]
  6. 2000, Handbook of lipoprotein testing, 625
  7. 15. Cole TG, Contois JH, Csako G, McConnell JP, Remaley AT, Devaraj S, et al. Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC lipoprotein and vascular diseases division working group on best practices. Clin Chem 2013;59:752–70.10.1373/clinchem.2012.196733Search in Google Scholar PubMed · doi:10.1373/clinchem.2012.196733search
  8. 67. Kulkarni KR, Garber DW, Schmidt CF, Marcovina SM, Ho MH, Wilhite BJ, et al. Analysis for cholesterol in all lipoprotein classes by single vertical ultracentrifugation of fingerstick blood and controlled-dispersion flow analysis. Clin Chem 1992;38:1898–905.10.1093/clinchem/38.9.1898Search in Google Scholar · doi:10.1093/clinchem/38.9.1898search
  9. 17. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. J Am Med Assoc 1996;276:875–81.10.1001/jama.1996.03540110029028Search in Google Scholar · doi:10.1001/jama.1996.03540110029028search
  10. 14. Contois JH, McConnell JP, Sethi AA, Csako G, Devaraj S, Hoefner DM, et al. Apolipoprotein B and cardiovascular disease risk: position statement from the AACC lipoproteins and vascular diseases division working group on best practices. Clin Chem 2009;55:407–19.10.1373/clinchem.2008.118356Search in Google Scholar PubMed · doi:10.1373/clinchem.2008.118356search
  11. 40. Varady KA, Lamarche B. Lipoprint adequately estimates LDL size distribution, but not absolute size, versus polyacrylamide gradient gel electrophoresis. Lipids 2011;46:1163–7.10.1007/s11745-011-3611-8Search in Google Scholar · doi:10.1007/s11745-011-3611-8search
  12. 23. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of Ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345–53.10.1172/JCI103182Search in Google Scholar · doi:10.1172/jci103182search
  13. 11. Nave AH, Lange KS, Leonards CO, Siegerink B, Doehner W, Landmesser U, et al. Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis. Atherosclerosis 2015;242:496–503.10.1016/j.atherosclerosis.2015.08.021Search in Google Scholar PubMed · doi:10.1016/j.atherosclerosis.2015.08.021search
  14. 2014, Accurate serum apolipoprotein A-I and B measurement using the agilent 1290 infinity LC and 6490 triple quadrupole LC/MS system, Agilent Application Note, 1
  15. 75. Mallol Parera R. Development and evaluation of a novel advanced lipoprotein test based on 2D diffusion ordered 1H-NMR spectroscopy [thesis]. Taragona, Universita Rovira I Virgili; 2014.10.1016/j.atherosclerosis.2014.05.647Search in Google Scholar · doi:10.1016/j.atherosclerosis.2014.05.647search
  16. 37. Noble RP. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res 1968;9:693–700.10.1016/S0022-2275(20)42680-XSearch in Google Scholar · doi:10.1016/s0022-2275(20)42680-xsearch
  17. 45. Okazaki M, Shiraishi K, Ohno Y, Hara I. High performance aqueous gel permeation chromatography of serum lipoproteins: selective detection of cholesterol by enzymatic reaction. J Chromatogr – Biomed Appl 1981;223:285–93.10.1016/S0378-4347(00)80100-0Search in Google Scholar · doi:10.1016/s0378-4347(00)80100-0search
  18. 20. Phillips CM, Perry IJ. Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: does size matter? Atherosclerosis 2015;242:399–406.10.1016/j.atherosclerosis.2015.07.040Search in Google Scholar PubMed · doi:10.1016/j.atherosclerosis.2015.07.040search
  19. 26. Caslake MJ, Packard CJ. The use of Ultracentrifugation for the separation of lipoproteins. In: Rifai N, Warnick GR, Dominiczak MH, editors. Handbook of lipoprotein testing, 2nd ed. Washington, DC: AACC Press, 2000:625–46.Search in Google Scholar
  20. 77. Lounila J, Ala-Korpela M, Jokisaari J, Savolainen MJ, Kesäniemi YA. Effects of orientational order and particle size on the NMR line positions of lipoproteins. Phys Rev Lett 1994;72:4049–52.10.1103/PhysRevLett.72.4049Search in Google Scholar · doi:10.1103/physrevlett.72.4049search
  21. 99. Davidson MH. Low-density lipoprotein cholesterol, non-high-density lipoprotein, apolipoprotein, or low-density lipoprotein particle: what should clinicians measure? J Am Coll Cardiol 2012;60:2616–7.10.1016/j.jacc.2012.06.065Search in Google Scholar PubMed · doi:10.1016/j.jacc.2012.06.065search
  22. 28. Greenspan P, Mao FW, Ryu BH, Gutman RL. Advances in agarose gel electrophoresis of serum lipoproteins. J Chromatogr A 1995;698:333–9.10.1016/0021-9673(94)01192-HSearch in Google Scholar · doi:10.1016/0021-9673(94)01192-hsearch
  23. 8. Everett BM, Ridker PM. Biomarkers for cardiovascular screening: progress or passé? Clin Chem 2017;63:248–51.10.1373/clinchem.2016.254854Search in Google Scholar PubMed · doi:10.1373/clinchem.2016.254854search
  24. 2000, Handbook of Lipoprotein Testing, 609
  25. 91. Stolzenburg MR, McMurry PH. An ultrafine aerosol condensation nucleus counter. Aerosol Sci Technol 1991;14:48–65.10.1080/02786829108959470Search in Google Scholar · doi:10.1080/02786829108959470search
  26. 16. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990;82:495–506.10.1161/01.CIR.82.2.495Search in Google Scholar · doi:10.1161/01.cir.82.2.495search
  27. 2008, Apo B measurement system and method. WO 2008130686 A1
  28. 5. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007;370:1829–39.10.1016/S0140-6736(07)61778-4Search in Google Scholar · doi:10.1016/s0140-6736(07)61778-4search
  29. 33. Mora S, Caulfield MP, Wohlgemuth J, Chen Z, Superko HR, Rowland CM, et al. Atherogenic lipoprotein subfractions determined by ion mobility and first cardiovascular events after random allocation to high-intensity statin or placebo: the JUPITER Trial. Circulation 2015;132:2220–9.10.1161/CIRCULATIONAHA.115.016857Search in Google Scholar · doi:10.1161/circulationaha.115.016857search
  30. 51. Okazaki M. Method for analyzing lipoproteins. WO/2015/152371, 2015.Search in Google Scholar
  31. 29. Bhatnagar D, Durrington PN. Measurement and clinical significance of apolipoproteins A-1 and B. In: Rifai N, Warnick GR, Dominiczak MH, editors. Handbook of lipoprotein testing, 2nd ed. Washington, DC: AACC Press, 2000:287–310.Search in Google Scholar
  32. 98. Davidson MH, Ballantyne CM, Jacobson TA, Bittner VA, Braun LT, Brown AS, et al. Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists. J Clin Lipidol 2011;5:338–67.10.1016/j.jacl.2011.07.005Search in Google Scholar PubMed · doi:10.1016/j.jacl.2011.07.005search
  33. 81. Mallol R, Rodríguez MA, Heras M, Vinaixa M, Plana N, Masana L, et al. Particle size measurement of lipoprotein fractions using diffusion-ordered NMR spectroscopy. Anal Bioanal Chem 2012;402:2407–15.10.1007/s00216-011-5705-9Search in Google Scholar · doi:10.1007/s00216-011-5705-9search
  34. 59. Kay RG, Gregory B, Grace PB, Pleasance S. The application of ultra-performance liquid chromatography/tandem mass spectrometry to the detection and quantitation of apolipoproteins in human serum. Rapid Commun Mass Spectrom 2010;21:2585–93.10.1002/rcm.3130Search in Google Scholar PubMed · doi:10.1002/rcm.3130search
  35. 44. Hara I, Okazaki M, Ohno Y. Rapid analysis of cholesterol of high density lipoprotein and low density lipoprotein in human serum by high performance liquid chromatography. J Biochem 1980;87:1863–5.10.1093/oxfordjournals.jbchem.a132933Search in Google Scholar · doi:10.1093/oxfordjournals.jbchem.a132933search
  36. 76. Otvos JD, Jeyarajah EJ, Bennett DW. Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. Clin Chem 1991;37:377–86.10.1093/clinchem/37.3.377Search in Google Scholar · doi:10.1093/clinchem/37.3.377search
  37. 27. Schmitz G, Böttcher A, Barlage S, Lackner KJ. New approaches to the use of electrophoresis in the clinical laboratory. In: Rifai N, Warnick GR, Dominiczak MH, editors. Handbook of lipoprotein testing, 2nd ed. Washington, DC: AACC Press, 2000:593–607.Search in Google Scholar
  38. 68. Kulkarni KR, Garber DW, Jones MK, Segrest JP. Identification and cholesterol quantification of low density lipoprotein subclasses in young adults by VAP-II methodology. J Lipid Res 1995;36:2291–302.10.1016/S0022-2275(20)39710-8Search in Google Scholar · doi:10.1016/s0022-2275(20)39710-8search
  39. 22. Master SR, Rader DJ. Beyond LDL cholesterol in assessing cardiovascular risk: apo B or LDL-P? Clin Chem 2013;59:723–5.10.1373/clinchem.2013.203208Search in Google Scholar PubMed · doi:10.1373/clinchem.2013.203208search
  40. 13. Sniderman AD, Williams K, Contois JH, Monroe HM, McQueen MJ, De Graaf J, et al. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein b as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes 2011;4:337–45.10.1161/CIRCOUTCOMES.110.959247Search in Google Scholar PubMed · doi:10.1161/circoutcomes.110.959247search
  41. 42. Ensign W, Hill N, Heward CB. Disparate LDL phenotypic classification among 4 different methods assessing LDL particle characteristics. Clin Chem 2006;52:1722–7.10.1373/clinchem.2005.059949Search in Google Scholar · doi:10.1373/clinchem.2005.059949search
  42. 88. Guha S, Li M, Tarlov MJ, Zachariah MR. Electrospray-differential mobility analysis of bionanoparticles. Trends Biotechnol 2012;30:291–300.10.1016/j.tibtech.2012.02.003Search in Google Scholar PubMed · doi:10.1016/j.tibtech.2012.02.003search
  43. 78. Jeyarajah EJ, Cromwell WC, Otvos JD. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 2006;26:847–70.10.1016/j.cll.2006.07.006Search in Google Scholar · doi:10.1016/j.cll.2006.07.006search
  44. 9. Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 2010;31:2844–53.10.1093/eurheartj/ehq386Search in Google Scholar PubMed PubMed Central · doi:10.1093/eurheartj/ehq386search
  45. 2014, Advanced lipoprotein testing: strengths and limitations [Internet]
  46. 85. Benner WH, Krauss RM, Blanche PJ. Ion mobility analysis of lipoproteins. WO 20100213061, 2010.Search in Google Scholar
  47. 2015, Method for the characterization of lipoproteins. WO 2015 079000 A1
  48. 70. Kulkarni KR. Apo B measurement system and method. WO 2008130686 A1, 2008.Search in Google Scholar
  49. 96. Fink PC, Römer M, Haeckel R. Measurement of proteins with the Behring nephelometer – a multicentre evaluation. Clin Chem Lab Med 1989;27:261–77.Search in Google Scholar
  50. 2000, Handbook of lipoprotein testing, 287
  51. 74. Mallol R, Amigo N, Rodriguez MA, Heras M, Vinaixa M, Plana N, et al. Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy. J Lipid Res 2015;56:737–46.10.1194/jlr.D050120Search in Google Scholar PubMed PubMed Central · doi:10.1194/jlr.d050120search
  52. 24. Noble RP, Hatch FT, Mazrimas JA, Lundgren FT, Jensen LC, Adamson GL. Comparison of lipoprotein analysis by agarose gel and paper electrophoresis with analytical ultracentrifugation. Lipids 1969;4:55–9.10.1007/BF02531795Search in Google Scholar · doi:10.1007/bf02531795search
  53. 50. Okazaki M, Yamashita S. Recent advances in analytical methods on lipoprotein subclasses: calculation of particle numbers from lipid levels by gel permeation HPLC using “spherical particle model”. J Oleo Sci 2016;65:265–82.10.5650/jos.ess16020Search in Google Scholar · doi:10.5650/jos.ess16020search
  54. 64. Albers JJ, Marcovina SM, Kennedy H. International federation of clinical chemistry standardization project for measurements of apolipoproteins A-I and B. II. Evaluation and selection of candidate reference materials. Clin Chem 1992;38:658–62.10.1093/clinchem/38.5.658Search in Google Scholar · doi:10.1093/clinchem/38.5.658search
  55. 46. Hara I, Okazaki M. High-performance liquid chromatography of serum lipoproteins. Methods Enzymol 1986;129:57–78.10.1016/0076-6879(86)29062-XSearch in Google Scholar · doi:10.1016/0076-6879(86)29062-xsearch
  56. 52. Van Gent T, Van Tol A. Automated gel permeation chromatography of plasma lipoproteins by preparative fast protein liquid chromatography. J Chromatogr B Biomed Appl 1990;525:433–41.10.1016/S0378-4347(00)83420-9Search in Google Scholar · doi:10.1016/s0378-4347(00)83420-9search
  57. 57. Ellerbe P, Sniegoski LT, Welch MJ. Isotope dilution mass spectrometry as a candidate definitive method for determining total glycerides and triglycerides in serum. Clin Chem 1995;41:397–404.10.1093/clinchem/41.3.397Search in Google Scholar · doi:10.1093/clinchem/41.3.397search
  58. 12. Khera AV, Everett BM, Caulfield MP, Hantash FM, Wohlgemuth J, Ridker PM, et al. Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER trial (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin). Circulation 2014;129:635–42.10.1161/CIRCULATIONAHA.113.004406Search in Google Scholar PubMed PubMed Central · doi:10.1161/circulationaha.113.004406search
  59. 48. Okazaki M, Usui S, Hosaki S. Analysis of plasma lipoproteins by gel permeation chromatography. In: Rifai N, Warnick GR, Dominiczak MH, editors. Handbook of lipoprotein testing, 2nd ed. 2000:647–69.Search in Google Scholar
  60. 93. Grundy SM, Vega GL, Tomassini JE, Tershakovec AM. Comparisons of apolipoprotein B levels estimated by immunoassay, nuclear magnetic resonance, vertical auto profile, and non-high-density lipoprotein cholesterol in subjects with hypertriglyceridemia (SAFARI Trial). Am J Cardiol 2011;108:40–6.10.1016/j.amjcard.2011.03.003Search in Google Scholar · doi:10.1016/j.amjcard.2011.03.003search
  61. 83. Matyus SP, Braun PJ, Wolak-Dinsmore J, Jeyarajah EJ, Shalaurova I, Xu Y, et al. NMR measurement of LDL particle number using the Vantera clinical analyzer. Clin Biochem 2014;47:203–10.10.1016/j.clinbiochem.2014.07.015Search in Google Scholar · doi:10.1016/j.clinbiochem.2014.07.015search
  62. 38. Hoefner DM, Hodel SD, O’Brien JF, Branum EL, Sun D, Meissner I, et al. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix lipoprint LDL system. Clin Chem 2001;47:266–74.10.1093/clinchem/47.2.266Search in Google Scholar · doi:10.1093/clinchem/47.2.266search
  63. 47. Toshima G, Iwama Y, Kimura F, Matsumoto Y, Miura M. LipoSEARCH ® Analytical GP-HPLC method for lipoprotein profiling and its applications. J Biol Macromol 2013;13:21–32.Search in Google Scholar · DOI
  64. 43. Schmitz G, Möllers C, Richter V. Analytical capillary isotachophoresis of human serum lipoproteins. Electrophoresis 1997;18:1807–13.10.1002/elps.1150181015Search in Google Scholar · doi:10.1002/elps.1150181015search
  65. 60. Agger SA, Marney LC, Hoofnagle AN. Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple-reaction-monitoring mass spectrometry. Clin Chem 2011;56:1804–13.10.1373/clinchem.2010.152264Search in Google Scholar PubMed PubMed Central · doi:10.1373/clinchem.2010.152264search
  66. 63. Hoofnagle AN, Whiteaker JR, Carr SA, Kuhn E, Liu T, Massoni SA, et al. Recommendations for the generation, quantification, storage, and handling of peptides used for mass spectrometry-based assays. Clin Chem 2016;62:48–69.10.1373/clinchem.2015.250563Search in Google Scholar PubMed PubMed Central · doi:10.1373/clinchem.2015.250563search
  67. 71. Kulkarni KR, Garber DW, Marcovina SM, Segrest JP. Quantification of cholesterol in all lipoprotein classes by the VAP-II method. J Lipid Res 1994;35:159–68.10.1016/S0022-2275(20)40123-3Search in Google Scholar · doi:10.1016/s0022-2275(20)40123-3search
  68. 6. Mora S, Wenger NK, Demicco DA, Breazna A, Boekholdt SM, Arsenault BJ, et al. Determinants of residual risk in secondary prevention patients treated with high-versus low-dose statin therapy: the treating to new targets (TNT) study. Circulation 2012;125:1979–87.10.1161/CIRCULATIONAHA.111.088591Search in Google Scholar · doi:10.1161/circulationaha.111.088591search
  69. 54. Garber DW, Kulkarni KR, Anantharamaiah GM. A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples. J Lipid Res 2000;41:1020–6.10.1016/S0022-2275(20)32045-9Search in Google Scholar · doi:10.1016/s0022-2275(20)32045-9search
  70. 19. Mora S, Szklo M, Otvos JD, Greenland P, Psaty BM, Goff DC, et al. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007;192:211–7.10.1016/j.atherosclerosis.2006.05.007Search in Google Scholar PubMed · doi:10.1016/j.atherosclerosis.2006.05.007search
  71. 53. März W, Siekmeier R, Scharnagl H, Seiffert UB, Gross W. Fast lipoprotein chromatography: new method of analysis for plasma lipoproteins. Clin Chem 1993;39:2276–81.10.1093/clinchem/39.11.2276Search in Google Scholar · doi:10.1093/clinchem/39.11.2276search
  72. 21. Otvos JD, Collins D, Freedman DS, Shalaurova I, Schaefer EJ, McNamara JR, et al. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation 2006;113:1556–63.10.1161/CIRCULATIONAHA.105.565135Search in Google Scholar PubMed · doi:10.1161/circulationaha.105.565135search
  73. 55. Usui S, Nakamura M, Jitsukata K, Nara M, Hosaki S, Okazaki M. Assessment of between-instrument variations in a HPLC method for serum lipoproteins and its traceability to reference methods for total cholesterol and HDL-cholesterol. Clin Chem 2000;46:63–72.10.1093/clinchem/46.1.63Search in Google Scholar · doi:10.1093/clinchem/46.1.63search
  74. 82. Mallol R, Rodríguez MA, Heras M, Vinaixa M, Cañellas N, Brezmes J, et al. Surface fitting of 2D diffusion-edited 1H NMR spectroscopy data for the characterisation of human plasma lipoproteins. Metabolomics 2011;7:572–82.10.1007/s11306-011-0273-8Search in Google Scholar · doi:10.1007/s11306-011-0273-8search
  75. 69. Chung BBH, Segrest JP, Ray MJ, Brunzell JD, Hokanson JE, Krauss RM, et al. Single vertical spin density gradient ultracentrifugation. Methods Enzymol 1986;128:181–209.10.1016/0076-6879(86)28068-4Search in Google Scholar · doi:10.1016/0076-6879(86)28068-4search
  76. 2002, Reference materials for the standardization of the apolipoproteins A-I and B and lipoprotein(a) [Internet], e-Journal of the International Federation of Clinical Chemistry and Laboratory Medicine, 13
  77. 92. Motzkus C, Macé T, Gaie-levrel F, Ducourtieux S, Delvallee A, Dirscherl K, et al. Size characterization of airborne SiO2 nanoparticles with on-line and off-line measurement techniques: an interlaboratory comparison study. J Nanoparticle Res 2013;15:1919.10.1007/s11051-013-1919-4Search in Google Scholar · doi:10.1007/s11051-013-1919-4search
  78. 100. Henrique Nacimento Harada P, Akinkuolie AO, Samia Mora. Advanced lipoprotein testing: strengths and limitations [Internet]. American College of Cardiology 2014. Cited 22 Nov 2016. Available from: http://www.acc.org/latest-in-cardiology/articles/2014/08/25/15/07/advanced-lipoprotein-testing-strengths-and-limitations.Search in Google Scholar Received: 2017-1-31 Accepted: 2017-3-27 Published Online: 2017-5-8 Published in Print: 2017-8-28 ©2017 Walter de Gruyter GmbH, Berlin/Boston Skip Articles in the same Issue Articles in the same Issue Frontmatter Editorials Reporting LDL-cholesterol levels in the era of intensive lipid management: a clarion call The challenges of genetic risk scores for the prediction of coronary heart disease Reviews Advanced lipoprotein testing for cardiovascular diseases risk assessment: a review of the novel approaches in lipoprotein profiling A review of the challenge in measuring and standardizing BCR-ABL1 Mini Review Challenges in the analysis of epigenetic biomarkers in clinical samples Opinion Paper Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: a consensus statement on behalf of the IFCC Working Group “Laboratory Error and Patient Safety” and EFLM Task and Finish Group “Performance specifications for the extra-analytical phases” Genetics and Molecular Diagnostics Assessment of EGFR mutation status using cell-free DNA from bronchoalveolar lavage fluid General Clinical Chemistry and Laboratory Medicine A survey of patients’ views from eight European countries of interpretive support from Specialists in Laboratory Medicine Verification of examination procedures in clinical laboratory for imprecision, trueness and diagnostic accuracy according to ISO 15189:2012: a pragmatic approach Expressing analytical performance from multi-sample evaluation in laboratory EQA A candidate reference method for serum potassium measurement by inductively coupled plasma mass spectrometry Practical motives are prominent in test-ordering in the Emergency Department Technical and clinical validation of the Greiner FC-Mix glycaemia tube Comparison of pneumatic tube system with manual transport for routine chemistry, hematology, coagulation and blood gas tests Accuracy of cerebrospinal fluid Aβ1-42 measurements: evaluation of pre-analytical factors using a novel Elecsys immunosassay Evaluation of cannabinoids concentration and stability in standardized preparations of cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem mass spectrometry Analytical performance and diagnostic accuracy of six different faecal calprotectin assays in inflammatory bowel disease Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseases Hematology and Coagulation Critical appraisal of discriminant formulas for distinguishing thalassemia from iron deficiency in patients with microcytic anemia Reference Values and Biological Variations Reference ranges of thromboelastometry in healthy full-term and pre-term neonates Cancer Diagnostics Immunoparesis in IgM gammopathies as a useful biomarker to predict disease progression Cardiovascular Diseases Assessment of the clinical utility of adding common single nucleotide polymorphism genetic scores to classical risk factor algorithms in coronary heart disease risk prediction in UK men Time and age dependent decrease of NT-proBNP after septal myectomy in hypertrophic obstructive cardiomyopathy Infectious Diseases Higher serum caspase-cleaved cytokeratin-18 levels during the first week of sepsis diagnosis in non-survivor patients Letters to the Editor Data mining for age-related TSH reference intervals in adulthood Intra-laboratory variation and its effect on gestational diabetes diagnosis Evaluation of long-term imprecision of automated complete blood cell count on the Sysmex XN-9000 system Sensitivity of the Sysmex XN9000 WPC-channel for detection of monoclonal B-cell populations Evaluation of biotin interference on immunoassays: new data for troponin I, digoxin, NT-Pro-BNP, and progesterone Stability of procalcitonin in cerebrospinal fluid Between-laboratory analysis of IgG antibodies against Aspergillus fumigatus in paired quality control samples Mass spectrometry vs. immunoassay in clinical and forensic toxicology: qui modus in rebus est? Great need for changes in higher education in Greece A note from the Editor in Chief regarding the Letter to the Editor “Great need for changes in higher education in Greece” Readers are also interested in: article: A step forward in the harmonization of tests for the hypothalamus–pituitary–adrenal axis function: the Netherland model A step forward in the harmonization of tests for the hypothalamus–pituitary–adrenal axis function: the Netherland model article: Reagent-specific anti-Xa DOAC safety cutoffs can be established using multiple LMWH-calibrated anti-Xa assays Reagent-specific anti-Xa DOAC safety cutoffs can be established using multiple LMWH-calibrated anti-Xa assays article: Systematic bias in point-of-care INR testing: comparative analysis of Abbott and Roche devices Systematic bias in point-of-care INR testing: comparative analysis of Abbott and Roche devices https://doi.org/10.1515/cclm-2017-0091 Keywords for this article advanced lipoprotein testing; cardiovascular diseases; ES-DMA; immunoassays; LC-MS/MS; NMR Skip Articles in the same Issue Articles in the same Issue Frontmatter Editorials Reporting LDL-cholesterol levels in the era of intensive lipid management: a clarion call The challenges of genetic risk scores for the prediction of coronary heart disease Reviews Advanced lipoprotein testing for cardiovascular diseases risk assessment: a review of the novel approaches in lipoprotein profiling A review of the challenge in measuring and standardizing BCR-ABL1 Mini Review Challenges in the analysis of epigenetic biomarkers in clinical samples Opinion Paper Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: a consensus statement on behalf of the IFCC Working Group “Laboratory Error and Patient Safety” and EFLM Task and Finish Group “Performance specifications for the extra-analytical phases” Genetics and Molecular Diagnostics Assessment of EGFR mutation status using cell-free DNA from bronchoalveolar lavage fluid General Clinical Chemistry and Laboratory Medicine A survey of patients’ views from eight European countries of interpretive support from Specialists in Laboratory Medicine Verification of examination procedures in clinical laboratory for imprecision, trueness and diagnostic accuracy according to ISO 15189:2012: a pragmatic approach Expressing analytical performance from multi-sample evaluation in laboratory EQA A candidate reference method for serum potassium measurement by inductively coupled plasma mass spectrometry Practical motives are prominent in test-ordering in the Emergency Department Technical and clinical validation of the Greiner FC-Mix glycaemia tube Comparison of pneumatic tube system with manual transport for routine chemistry, hematology, coagulation and blood gas tests Accuracy of cerebrospinal fluid Aβ1-42 measurements: evaluation of pre-analytical factors using a novel Elecsys immunosassay Evaluation of cannabinoids concentration and stability in standardized preparations of cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem mass spectrometry Analytical performance and diagnostic accuracy of six different faecal calprotectin assays in inflammatory bowel disease Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseases Hematology and Coagulation Critical appraisal of discriminant formulas for distinguishing thalassemia from iron deficiency in patients with microcytic anemia Reference Values and Biological Variations Reference ranges of thromboelastometry in healthy full-term and pre-term neonates Cancer Diagnostics Immunoparesis in IgM gammopathies as a useful biomarker to predict disease progression Cardiovascular Diseases Assessment of the clinical utility of adding common single nucleotide polymorphism genetic scores to classical risk factor algorithms in coronary heart disease risk prediction in UK men Time and age dependent decrease of NT-proBNP after septal myectomy in hypertrophic obstructive cardiomyopathy Infectious Diseases Higher serum caspase-cleaved cytokeratin-18 levels during the first week of sepsis diagnosis in non-survivor patients Letters to the Editor Data mining for age-related TSH reference intervals in adulthood Intra-laboratory variation and its effect on gestational diabetes diagnosis Evaluation of long-term imprecision of automated complete blood cell count on the Sysmex XN-9000 system Sensitivity of the Sysmex XN9000 WPC-channel for detection of monoclonal B-cell populations Evaluation of biotin interference on immunoassays: new data for troponin I, digoxin, NT-Pro-BNP, and progesterone Stability of procalcitonin in cerebrospinal fluid Between-laboratory analysis of IgG antibodies against Aspergillus fumigatus in paired quality control samples Mass spectrometry vs. immunoassay in clinical and forensic toxicology: qui modus in rebus est? Great need for changes in higher education in Greece A note from the Editor in Chief regarding the Letter to the Editor “Great need for changes in higher education in Greece”
  79. 58. Barr JR, Maggio VL, Patterson DG, Cooper GR, Henderson LO, Turner WE, et al. Isotope-dilution mass spectrometric quantification of specific proteins: model application with apolipoprotein A-1. Clin Chem 1996;42:1676–82.10.1093/clinchem/42.10.1676Search in Google Scholar · doi:10.1093/clinchem/42.10.1676search
  80. 80. Parera Mallol R, Amigo N, Correig X, Masparena M, Martinez L, Rodriguez M-Á, et al. Method for the characterization of lipoproteins. WO 2015 079000 A1, 2015.Search in Google Scholar
  81. 2000, Handbook of lipoprotein testing, 593
  82. 62. Smit NP, Romijn FP, Van Den Broek I, Van Der Burgt YE, Cobbaert CM. Accurate serum apolipoprotein A-I and B measurement using the agilent 1290 infinity LC and 6490 triple quadrupole LC/MS system. Agilent Application Note 2014;1–8.Search in Google Scholar
  83. 84. Kaufman SL. Analysis of biomolecules using electrospray and nanoparticle methods: the gas-phase electrophoretic mobility molecular analyzer (GEMMA). J Aerosol Sci 1998;29:537–52.10.1016/S0021-8502(97)00462-XSearch in Google Scholar · doi:10.1016/s0021-8502(97)00462-xsearch
  84. 94. Dati F, Tate J. Reference materials for the standardization of the apolipoproteins A-I and B, and lipoprotein(a) [Internet]. Vol. 13, e-Journal of the International Federation of Clinical Chemistry and Laboratory Medicine. 2002. Available from: http://www.ifcc.org/ejifcc/vol13no3/130301003.htm.Search in Google Scholar
  85. 1999, Analysis of apolipoproteins and lipoproteins by capillary electrophoresis, Electrophoresis, 2, 2118
  86. 65. Chung BH, Segrest JP, Cone JT, Pfau J, Geer JC, Duncan LA. High-resolution plasma-lipoprotein cholesterol profiles by a rapid, high volume semi-automated method. J Lipid Res 1981;22:1003–14.10.1016/S0022-2275(20)37338-7Search in Google Scholar · doi:10.1016/s0022-2275(20)37338-7search
  87. 49. Tadey T, Purdy WC. Chromatographic techniques for the isolation and purification of lipoproteins. J Chromatogr B Biomed Appl 1995;671:237–53.10.1016/0378-4347(95)00051-JSearch in Google Scholar · doi:10.1016/0378-4347(95)00051-jsearch
  88. 34. Thompson A, Danesh J. Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies. J Intern Med 2006;259:481–92.10.1111/j.1365-2796.2006.01644.xSearch in Google Scholar · doi:10.1111/j.1365-2796.2006.01644.xsearch
  89. 87. Musunuru K, Orho-Melander M, Caulfield MP, Li S, Salameh WA, Reitz RE, et al. Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk. Arterioscler Thromb Vasc Biol 2009;29:1975–80.10.1161/ATVBAHA.109.190405Search in Google Scholar PubMed PubMed Central · doi:10.1161/atvbaha.109.190405search
  90. 2000, Handbook of lipoprotein testing, 647
  91. 89. Hutchins PM, Ronsein GE, Monette JS, Pamir N, Wimberger J, He Y, et al. Quantification of HDL particle concentration by calibrated ion mobility analysis. Clin Chem 2014;60: 1393–401.10.1373/clinchem.2014.228114Search in Google Scholar PubMed PubMed Central · doi:10.1373/clinchem.2014.228114search
  92. 66. Cone JT, Segrest JP, Chung BH, Ragland JB, Sabesin SM, Glasscock A. Computerized rapid high resolution quantitative analysis of plasma lipoproteins based upon single vertical spin centrifugation. J Lipid Res 1982;23:923–35.10.1016/S0022-2275(20)38096-2Search in Google Scholar · doi:10.1016/s0022-2275(20)38096-2search
  93. 97. Albers JJ, Lodge MS, Curtiss LK. Evaluation of a monoclonal antibody-based enzyme-linked immunosorbent assay as a candidate reference method for the measurement of apolipoprotein B-100. J Lipid Res 1989;30:1445–58.10.1016/S0022-2275(20)38265-1Search in Google Scholar · doi:10.1016/s0022-2275(20)38265-1search
  94. 2010, Lipoprotein particle profiles by NMR compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women, Circulation, 119, 931
  95. 31. Labeur C, Shepherd J, Rosseneu M. Immunological assays of apolipoproteins in plasma: methods and instrumentation. Clin Chem 1990;36:591–7.10.1093/clinchem/36.4.591Search in Google Scholar · doi:10.1093/clinchem/36.4.591search
  96. 2015, Method for analyzing lipoproteins
  97. 2014, 2013 ACC/AHA Guideline on the assessment of cardiovascular risk – a report of the American College of Cardiology/American Heart Association task force on practice guidelines, J Am Coll Cardiol, 63, 2935
  98. 2000, Handbook of lipoprotein testing, 647
  99. 61. Toth CA, Kuklenyik Z, Jones JI, Parks BA, Gardner MS, Schieltz DM, et al. On-column trypsin digestion coupled with LC-MS/MS for quantification of apolipoproteins. J Proteomics 2017;150:258–67.10.1016/j.jprot.2016.09.011Search in Google Scholar PubMed · doi:10.1016/j.jprot.2016.09.011search
  100. 90. Clouet-Foraison N, Gaie-levrel F, Coquelin L, Ebrard G, Gillery P, Delatour V. Absolute quantification of bio-nanoparticles by electrospray differential mobility analysis: an application to lipoprotein particle concentration measurements. Anal Chem 2017;89:2242–49.10.1021/acs.analchem.6b02909Search in Google Scholar · doi:10.1021/acs.analchem.6b02909search
  101. 86. Caulfield MP, Li S, Lee G, Blanche PJ, Salameh WA, Benner WH, et al. Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis. Clin Chem 2008;54:1307–16.10.1373/clinchem.2007.100586Search in Google Scholar PubMed · doi:10.1373/clinchem.2007.100586search

Cited by

See all 30

Metadata

Authors
Clouet-Foraison, N., Gaie-Levrel, F., Gillery, P., & Delatour, V.
Affiliations
  • Laboratoire National de Métrologie et d'Essais (FR)
  • Centre National de la Recherche Scientifique (FR)
Corresponding author
Delatour, Vincent
Venue
Clinical Chemistry and Laboratory Medicine (CCLM)
Published
2017-01-01
Volume
55
Issue
10
Pages
1453-1464
ISSN
  • 1434-6621 (ISSN-L)
  • 1437-4331
OpenAlex
W2613798300
Cited by
30
References
81
Citations by year
2025: 1 · 2024: 3 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 5 · 2019: 1 · 2018: 4 · 2017: 3
FWCI
0.75
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Chemistry and Laboratory Medicine (CCLM) (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
Keywords
cardiovascular disease risk assessment, cardiovascular biomarkers, lipoprotein quantification, method standardization, assay comparability, lipoprotein particles
MeSH terms
Cardiovascular Diseases, Chromatography, High Pressure Liquid, Electrophoresis, Polyacrylamide Gel, Humans, Immunoassay, Lipoproteins, Magnetic Resonance Spectroscopy, Mass Spectrometry, Biomarkers, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.